placeholder
Importance
22
Trust
71
Urgency
30
CLINICAL TRIAL
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine
Analysis
No article body is available. No grounded facts about AstraZeneca's obesity program or the $125M deal can be confirmed from this source.
BioPharma Dive10d
Read